Damieon Brown, DPM
Podiatrist · Jasper, TNNPI 1053335273
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.6%), food and beverage and other — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Smith+Nephew at 25.1% of the total. 2025 is the largest year on record at $7,003, 6.5 times the $1,079 reported in 2019. Among podiatrist clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 192 payments — averaging $64.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Mimedx Group, Inc.$3K
- Medline Industries LP$2K
- Kerecis Limited$1K
- Smoky Mountain Surgical LLC$765
- KCI USA, Inc.$651
- plus $2K from 24 others
What the payments were for
- Travel & lodging$6,36752%
- Food & beverage$5,89048%
- Other$871%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 75 | $3,104 |
| Mimedx Group, Inc. | 17 | $2,703 |
| Medline Industries LP | 9 | $1,593 |
| Kerecis Limited | 10 | $1,215 |
| Smoky Mountain Surgical LLC | 6 | $765 |
| KCI USA, Inc. | 6 | $651 |
| Arthrex | 13 | $486 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $255 |
| Organogenesis Inc. | 11 | $235 |
| AbbVie | 12 | $170 |
| Osiris Therapeutics Inc. | 1 | $149 |
| Bone Support Inc. | 1 | $144 |
| Paratek Pharmaceuticals, Inc. | 7 | $124 |
| Bsn Medical Inc | 3 | $122 |
| Integra Lifesciences Corporation | 2 | $116 |
| Biocomposites Inc | 1 | $104 |
| Medartis Inc. | 2 | $76 |
| Treace Medical Concepts, Inc. | 1 | $57 |
| Polymedics Innovations Inc. | 1 | $55 |
| Hartmann USA, Inc. | 2 | $37 |
| Triad Life Sciences Inc. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Lifenet Health | 1 | $21 |
| Molnlycke Health Care US, LLC | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Philips North America LLC | 1 | $16 |
| Urgo Medical North America, LLC | 1 | $16 |
| Alpha Orthopedic Systems | 1 | $14 |
| Hydrofera LLC | 1 | $14 |
| OVIK Health, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$3,619
- PICO$1,961
- Grafix$1,676
- Versajet$1,398
- COLLAGENASE SANTYL$1,398
- Kerecis GraftGuide$905
- SNAP$516
- Stravix$278
- GrafixPL$149
- CERAMENTBONE VOID FILLER$144
- CERAMENT G$144
- Oasis$129
- Stimulan$104
How this compares
$12,345 in reported general payments places this provider in the 90th percentile of 105 podiatrist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 38 | $30,316 |
| Naproxen Sodium | 30 | $1,099 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $580 |
| Terbinafine Hcl | 32 | $406 |
| Ampicillin Trihydrate | 18 | $245 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $243 |
| Doxycycline Hyclate | 11 | $162 |
| Clindamycin Hcl | 16 | $141 |
| Levofloxacin | 15 | $125 |
| Methylprednisolone | 15 | $120 |
| Mupirocin | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $3,104 | $30,31638 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 105 podiatrist providers in Tennessee.
Other podiatrist in Jasper
- Jeffrey LovelandSparta$809K
- Michael KingNashville$190K
- Penninah KumarMt Juliet$72K
- James HarrisTrenton$49K
- Matthew NeuhausSmyrna$33K
- Paul HutchisonMemphis$17K
- Sam BazrafshanChattanooga$16K
- Abshan MalikKnoxville$13K
- Christopher HendrixBartlett$13K
- Christina BridgesClarksville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.